From GlobeNewswire: 2025-02-26 10:05:00

The Tumor Profiling Market is set to skyrocket, with a projected value of USD 24.8 billion by 2032, expanding at a CAGR of 10.04%. Factors driving growth include the rise in cancer cases, genomic advancements, and personalized treatment adoption. Government funding for research is also boosting the market. Major players include Illumina, QIAGEN, and NeoGenomics. Genomics led the market in 2023, with sequencing technology dominating. Personalized cancer medicine was the top application, with North America leading the market. The U.S. leads the North American tumor profiling market with key companies like Illumina and Thermo Fisher Scientific. Government initiatives like the Cancer Moonshot program drive innovation in cancer research. Meanwhile, Asia-Pacific shows rapid growth due to advancements in healthcare infrastructure and collaborations with global pharmaceutical firms, especially in countries like China, India, and Japan.

In recent developments, Illumina launched the TruSight Oncology 500 HRD assay to enhance tumor profiling, while Roche Diagnostics received FDA approval for its AVENIO Tumor Tissue CGP Kit for comprehensive genomic profiling. These advancements reflect the growing importance of precision medicine in cancer treatment.

For in-depth analysis and insights on the Tumor Profiling Market, interested parties can purchase a Single-User PDF report for the period 2024-2032. The report covers a wide range of topics, including market dynamics, statistical insights, competitive landscape, regional analysis, and company profiles. Customization options are also available for specific research needs.

SNS Insider is a leading market research and consulting agency providing clients with up-to-date and accurate market data to make informed decisions. Through surveys, video talks, and focus groups, the company offers consumer insights and opinions globally. Enquiries for customized research on the Tumor Profiling Market can be made through their website.



Read more at GlobeNewswire: Tumor Profiling Market Projected to Surpass USD 24.8